M&A Strategy Leads Intervet to Kansas City
- Topics:
- Site Selection
- Tags:
- Finance,
- Financial Planning,
- Healthcare,
- Kansas City,
- M&A,
- Payroll Solutions,
- Site Selection,
- Taxes,
- Vaccine
- Source:
- bizsites.com
FREE Registration is required
Overview: The article is about site selection by vaccine manufacturer for building a major campus. An example says that Kansas City’s newest corporate entities is playing a key role in the Europeans’ battle against contagious cattle diseases. Intervet Inc., which recently selected the Kansas City area as the site of a new 315-acre campus, is one of the world’s largest manufacturers of a vaccine for foot-and-mouth disease (FMD). The article explains the site selection process, during the Intervet site-selection process, company officials negotiated an incentive package that included a “forgivable” loan, dollars for customized training, corporate income tax credits, investment tax credits and sales tax exemptions.
(Is this item miscategorized? Does it need more tags? Let us know.)
Format: HTML | Date: Aug 2001 | Pages: 1
People who downloaded this item also downloaded
 |
The Best Biotech Location |
